Biontech Se (BNTX) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access BNTX Annual Balance Sheets →
From Biontech Se through Dec 31 2024, shifts in Dec 31 2025's assets and liabilities provide insight into the company's capital structure and financial stability.
Quarterly Report, GAAP in USD millions
ITEM
(Dec 31 2025)
0 0 0 (Dec 31 2024)
Assets
Cash And Cash Equivalents8,596.45
Current Tax Assets Current58.91
Cash & Short-term Investments8,654.00
Inventories123.98
Other Current Assets9,304.85
Total Current Assets18,084.19
Equipment/Property/Plant Net1,210.61
Goodwill net412.05
Deferred Tax Assets15.12
Intangible AssetsAnd Goodwill4,905.26
Total Assets24,627.23
Liabilities
Other Liabilities, Current2,236.64
Current Provisions162.74
Total Current Liabilities2,399.38
Total Long-term Debt0.00
Deferred Tax Liabilities, Net LI94.42
Noncurrent Provisions602.34
Total Liabilities3,096.13
Stockholders' Equity
Other Equity21,531.10
Common Stockholder's Equity21,531.10
Total Stockholder's Equity21,531.10
Liabilities & Stockholder's Equity24,627.23
4 historic quarters locked

Sign in to unlock the full Biontech Se balance sheet history.

About Biontech Se Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 20-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001776985-26-000017

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.